Posters Overview
For the reaction phenotyping of slow-metabolizing compounds requiring high HLM concentrations or longer reaction times, amodiaquine is no longer suitable. Paclitaxel serves as a superior CYP2C8 probe substrate. Its use enables the assay to be performed under lower inhibitor concentrations, effectively minimizes off-target effects, and ensures the accurate identification of primary metabolic enzymes in drug metabolism studies.

Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.